{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T03:19:09Z","timestamp":1789874349545,"version":"4.0.1"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007353","name":"Fondation J\u00e9r\u00f4me Lejeune","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007353","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001673","name":"J\u00e9r\u00f4me Lejeune Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001673","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.neuint.2024.105679","type":"journal-article","created":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T06:36:10Z","timestamp":1706855770000},"page":"105679","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Early chronic fasudil treatment rescues hippocampal alterations in the Ts65Dn model for down syndrome"],"prefix":"10.1016","volume":"174","author":[{"given":"Rosa","family":"L\u00f3pez-Hidalgo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00fal","family":"Ballest\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"S\u00e1nchez-Mart\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Miguel","family":"Blasco-Ib\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Crespo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Nacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1996-2870","authenticated-orcid":false,"given":"Emilio","family":"Varea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2024.105679_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.nbd.2017.01.003","article-title":"Pharmacological rescue of adult hippocampal neurogenesis in a mouse model of X-linked intellectual disability","volume":"100","author":"Allegra","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2024.105679_bib2","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/ana.410070512","article-title":"Neurofibrillary tangles, granulovacuolar degeneration, and neuron loss in down syndrome: quantitative comparison with alzheimer dementia","volume":"7","author":"Ball","year":"1980","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2024.105679_bib3","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/ana.410200413","article-title":"Dendritic atrophy in children with Down's syndrome","volume":"20","author":"Becker","year":"1986","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2024.105679_bib4","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/cne.21895","article-title":"Excitatory-inhibitory relationship in the fascia dentata in the Ts65Dn mouse model of down syndrome","volume":"512","author":"Belichenko","year":"2009","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuint.2024.105679_bib5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/cne.20337","article-title":"Synaptic structural abnormalities in the Ts65Dn mouse model of Down Syndrome","volume":"480","author":"Belichenko","year":"2004","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuint.2024.105679_bib6","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1242\/jcs.000703","article-title":"The Down syndrome critical region protein TTC3 inhibits neuronal differentiation via RhoA and Citron kinase","volume":"120","author":"Berto","year":"2007","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.neuint.2024.105679_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093721","article-title":"The DCR protein TTC3 affects differentiation and Golgi compactness in neurons through specific actin-regulating pathways","volume":"9","author":"Berto","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2024.105679_bib8","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.0534-10.2010","article-title":"Early pharmacotherapy restores neurogenesis and cognitive performance in the Ts65Dn mouse model for down syndrome","volume":"30","author":"Bianchi","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2024.105679_bib9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1044-7431(02)00032-5","article-title":"Suppression of Rho-kinase activity promotes axonal growth on inhibitory CNS substrates","volume":"22","author":"Borisoff","year":"2003","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuint.2024.105679_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/S0300-9084(01)01293-7","article-title":"Roles, regulation, and mechanism of polysialic acid function during neural development","volume":"83","author":"Brus\u00e9s","year":"2001","journal-title":"Biochimie"},{"key":"10.1016\/j.neuint.2024.105679_bib11","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.0462-19.2020","article-title":"ROCK\/PKA inhibition rescues hippocampal hyperexcitability and GABAergic neuron alterations in a oligophrenin-1 knock-out mouse model of X-linked intellectual disability","volume":"40","author":"Busti","year":"2020","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2024.105679_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2020.147031","article-title":"Piriform cortex alterations in the Ts65Dn model for down syndrome","volume":"1747","author":"Carbonell","year":"2020","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2024.105679_bib13","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1517\/13543784.2013.778242","article-title":"Fasudil and its analogs: a new powerful weapon in the long war against central nervous system disorders?","volume":"22","author":"Chen","year":"2013","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.neuint.2024.105679_bib14","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nrn2373","article-title":"Actin in action: the interplay between the actin cytoskeleton and synaptic efficacy","volume":"9","author":"Cingolani","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuint.2024.105679_bib15","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.expneurol.2006.02.005","article-title":"Fluoxetine rescues deficient neurogenesis in hippocampus of the Ts65Dn mouse model for Down syndrome","volume":"200","author":"Clark","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2024.105679_bib16","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1172\/JCI64650","article-title":"Lithium rescues synaptic plasticity and memory in Down syndrome mice","volume":"123","author":"Contestabile","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuint.2024.105679_bib17","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3233\/JAD-2010-091114","article-title":"Increased dendrite branching in AbetaPP\/PS1 mice and elongation of dendrite arbors by fasudil administration","volume":"20","author":"Couch","year":"2010","journal-title":"J. Alzheimers. Dis."},{"key":"10.1016\/j.neuint.2024.105679_bib18","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.biopsych.2013.05.024","article-title":"Formoterol, a long-acting \u03b22 adrenergic agonist, improves cognitive function and promotes dendritic complexity in a mouse model of Down syndrome","volume":"75","author":"Dang","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuint.2024.105679_bib19","first-page":"263","article-title":"Segmental trisomy of murine chromosome 16: a new model system for studying Down syndrome","volume":"360","author":"Davisson","year":"1990","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/j.neuint.2024.105679_bib20","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/cercor\/13.7.758","article-title":"Alterations of neocortical pyramidal cell phenotype in the Ts65Dn mouse model of Down syndrome: effects of environmental enrichment","volume":"13","author":"Dierssen","year":"2003","journal-title":"Cereb. Cortex"},{"key":"10.1016\/j.neuint.2024.105679_bib21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.mcn.2009.11.001","article-title":"Fasudil, a Rho kinase inhibitor, drives mobilization of adult neural stem cells after hypoxia\/reoxygenation injury in mice","volume":"43","author":"Ding","year":"2010","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuint.2024.105679_bib22","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.bbi.2009.05.002","article-title":"Rho kinase inhibitor Fasudil induces neuroprotection and neurogenesis partially through astrocyte-derived G-CSF","volume":"23","author":"Ding","year":"2009","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuint.2024.105679_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121019","article-title":"Fasudil, a ROCK inhibitor, preserves limb integrity in a mouse model of unilateral critical limb ischemia: possible interplay of inflammatory and angiogenic signaling pathways","volume":"309","author":"El-Waseif","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.neuint.2024.105679_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104874","article-title":"Neonatal therapy with clenbuterol and salmeterol restores spinogenesis and dendritic complexity in the dentate gyrus of the Ts65Dn model of Down syndrome","volume":"140","author":"Emili","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2024.105679_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/S1044-7431(03)00078-2","article-title":"The RhoGAP activity of OPHN1, a new F-actin-binding protein, is negatively controlled by its amino-terminal domain","volume":"23","author":"Fauchereau","year":"2003","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuint.2024.105679_bib26","first-page":"267","article-title":"The impact of risk factors of Alzheimer's disease in the Down syndrome","volume":"11","author":"Folin","year":"2003","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.neuint.2024.105679_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2010.06.013","article-title":"Stimulated neuronal expression of brain-derived neurotrophic factor by Neurotropin","volume":"45","author":"Fukuda","year":"2010","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuint.2024.105679_bib28","first-page":"336","article-title":"The ROCK inhibitor Fasudil prevents chronic restraint stress-induced depressive-like behaviors and dendritic spine loss in rat hippocampus","volume":"20","author":"Garc\u00eda-Rojo","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuint.2024.105679_bib29","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2000-1-2-reviews0002","article-title":"The sequence of human chromosome 21 and implications for research into Down syndrome","volume":"1","author":"Gardiner","year":"2000","journal-title":"Genome Biol."},{"key":"10.1016\/j.neuint.2024.105679_bib30","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0378-1119(03)00769-8","article-title":"Mouse models of Down syndrome: how useful can they be? Comparison of the gene content of human chromosome 21 with orthologous mouse genomic regions","volume":"318","author":"Gardiner","year":"2003","journal-title":"Gene"},{"key":"10.1016\/j.neuint.2024.105679_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresrev.2007.05.014","article-title":"Polysialic acid-neural cell adhesion molecule in brain plasticity: from synapses to integration of new neurons","author":"Gascon","year":"2007","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neuint.2024.105679_bib32","doi-asserted-by":"crossref","first-page":"10741","DOI":"10.1523\/JNEUROSCI.2836-04.2004","article-title":"Brain-derived neurotrophic factor regulation of retinal growth cone filopodial dynamics is mediated through actin depolymerizing factor\/cofilin","volume":"24","author":"Gehler","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2024.105679_bib33","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1002\/jnr.21671","article-title":"Role of Rho kinase pathway in chondroitin sulfate proteoglycan-mediated inhibition of neurite outgrowth in PC12 cells","volume":"86","author":"Gopalakrishnan","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neuint.2024.105679_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/nn1210","article-title":"The X-linked mental retardation protein oligophrenin-1 is required for dendritic spine morphogenesis","volume":"7","author":"Govek","year":"2004","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuint.2024.105679_bib35","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1006\/exnr.1999.7289","article-title":"Loss of cholinergic phenotype in basal forebrain coincides with cognitive decline in a mouse model of Down's syndrome","volume":"161","author":"Granholm","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuint.2024.105679_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/srep32353","article-title":"An Integrated human\/murine transcriptome and pathway Approach to identify Prenatal treatments for down syndrome","volume":"6","author":"Guedj","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuint.2024.105679_bib37","doi-asserted-by":"crossref","DOI":"10.1111\/j.1750-3639.2012.00624.x","article-title":"Early pharmacotherapy with fluoxetine rescues dendritic pathology in the ts65dn mouse model of down syndrome","volume":"23","author":"Guidi","year":"2013","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neuint.2024.105679_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2018.e00669","article-title":"Automated analysis of images for molecular quantification in immunohistochemistry","volume":"4","author":"Guirado","year":"2018","journal-title":"Heliyon"},{"key":"10.1016\/j.neuint.2024.105679_bib39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1365-2818.1999.00457.x","article-title":"The efficiency of systematic sampling in stereology - Reconsidered","volume":"193","author":"Gundersen","year":"1999","journal-title":"J. Microsc."},{"key":"10.1016\/j.neuint.2024.105679_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577284","article-title":"Fasudil inhibits the activation of microglia and astrocytes of transgenic Alzheimer's disease mice via the downregulation of TLR4\/Myd88\/NF-\u03baB pathway","volume":"346","author":"Guo","year":"2020","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neuint.2024.105679_bib41","doi-asserted-by":"crossref","first-page":"651","DOI":"10.31083\/j.jin.2020.04.243","article-title":"Fasudil reduces \u03b2-amyloid levels and neuronal apoptosis in APP\/PS1 transgenic mice via inhibition of the Nogo-A\/NgR\/RhoA signaling axis","volume":"19","author":"Guo","year":"2020","journal-title":"J. Integr. Neurosci."},{"key":"10.1016\/j.neuint.2024.105679_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078561","article-title":"Alterations to dendritic spine morphology, but not dendrite patterning, of cortical projection neurons in Tc1 and Ts1Rhr mouse models of Down syndrome","volume":"8","author":"Haas","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2024.105679_bib43","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1042\/BST20120103","article-title":"Rho family GTPases","volume":"40","author":"Hall","year":"2012","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neuint.2024.105679_bib44","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11064-014-1479-8","article-title":"Altered distribution of hippocampal interneurons in the murine Down Syndrome model Ts65Dn","volume":"40","author":"Hern\u00e1ndez-Gonz\u00e1lez","year":"2015","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuint.2024.105679_bib45","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.npep.2011.10.002","article-title":"Altered expression of neuropeptides in the primary somatosensory cortex of the Down syndrome model Ts65Dn","volume":"46","author":"Hern\u00e1ndez","year":"2012","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neuint.2024.105679_bib46","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/archneur.1995.00540280065020","article-title":"Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease","volume":"52","author":"Hof","year":"1995","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neuint.2024.105679_bib47","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1046\/j.1365-2788.2000.00263.x","article-title":"Incidence and course of dementia in people with Down's syndrome: Findings from a population-based study","volume":"44","author":"Holland","year":"2000","journal-title":"J. Intellect. Disabil. Res."},{"key":"10.1016\/j.neuint.2024.105679_bib48","doi-asserted-by":"crossref","first-page":"13333","DOI":"10.1073\/pnas.93.23.13333","article-title":"Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome","volume":"93","author":"Holtzman","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2024.105679_bib49","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/cns.12002","article-title":"Fasudil ameliorates disease progression in experimental autoimmune encephalomyelitis, acting possibly through antiinflammatory effect","volume":"18","author":"Hou","year":"2012","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.neuint.2024.105679_bib50","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neuroscience.2011.10.030","article-title":"Changes in hippocampal synapses and learning-memory abilities in a streptozotocin-treated rat model and intervention by using fasudil hydrochloride","volume":"200","author":"Hou","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2024.105679_bib51","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ejphar.2008.11.053","article-title":"Inhibition of intracellular Ca2+ release by a Rho-kinase inhibitor for the treatment of ischemic damage in primary cultured rat hippocampal neurons","volume":"602","author":"Huang","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuint.2024.105679_bib52","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.stemcr.2018.02.001","article-title":"Modeling down syndrome with Patient iPSCs Reveals cellular and Migration deficits of GABAergic neurons","volume":"10","author":"Huo","year":"2018","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.neuint.2024.105679_bib53","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/bjp.2008.225","article-title":"Antiepileptic effects of two Rho-kinase inhibitors, Y-27632 and fasudil, in mice","volume":"155","author":"Inan","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuint.2024.105679_bib54","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0304-3940(98)00641-7","article-title":"Hippocampal volume and neuronal number in Ts65Dn mice: a murine model of Down syndrome","volume":"253","author":"Insausti","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuint.2024.105679_bib55","doi-asserted-by":"crossref","DOI":"10.1038\/nn964","article-title":"EphB receptors regulate dendritic spine development via intersectin, Cdc42 and N-WASP","volume":"5","author":"Irie","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuint.2024.105679_bib56","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbr.2018.05.024","article-title":"Fasudil hydrochloride ameliorates memory deficits in rat model of streptozotocin-induced Alzheimer's disease: Involvement of PI3-kinase, eNOS and NF\u03baB","volume":"351","author":"Kumar","year":"2018","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuint.2024.105679_bib57","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0006-8993(00)01984-3","article-title":"Synaptic deficit in the temporal cortex of partial trisomy 16 (Ts65Dn) mice","volume":"858","author":"Kurt","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2024.105679_bib58","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00109-016-1469-1","article-title":"The Rho kinase inhibitor, fasudil, ameliorates diabetes-induced cardiac dysfunction by improving calcium clearance and actin remodeling","volume":"95","author":"Lai","year":"2017","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.neuint.2024.105679_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/72920","article-title":"Rho GTPases regulate distinct aspects of dendritic arbor growth in Xenopus central neurons in vivo","volume":"3","author":"Li","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuint.2024.105679_bib60","doi-asserted-by":"crossref","DOI":"10.2144\/03356st02","article-title":"Quantitative PCR genotyping assay for the Ts65Dn mouse model of Down syndrome","volume":"35","author":"Liu","year":"2003","journal-title":"Biotechniques"},{"key":"10.1016\/j.neuint.2024.105679_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2016.00075","article-title":"Hypocellularity in the murine model for down syndrome Ts65Dn is not affected by adult neurogenesis","volume":"10","author":"L\u00f3pez-Hidalgo","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuint.2024.105679_bib62","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.brainres.2006.05.022","article-title":"Hippocampal hypocellularity in the Ts65Dn mouse originates early in development","volume":"1104","author":"Lorenzi","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2024.105679_bib63","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/cne.901670105","article-title":"Pyramidal cell abnormalities in the motor cortex of a child with Down's syndrome. A Golgi study","volume":"167","author":"Marin-Padilla","year":"1976","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuint.2024.105679_bib64","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0006-8993(01)03241-3","article-title":"PSA-NCAM expression in the piriform cortex of the adult rat. Modulation by NMDA receptor antagonist administration","volume":"927","author":"Nacher","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2024.105679_bib65","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1034\/j.1601-183X.2003.00026.x","article-title":"Down's syndrome: a genetic disorder in biobehavioral perspective","volume":"2","author":"Nadel","year":"2003","journal-title":"Genes, Brain Behav"},{"key":"10.1016\/j.neuint.2024.105679_bib66","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/neu.20153","article-title":"Rho GTPases, dendritic structure, and mental retardation","volume":"64","author":"Newey","year":"2005","journal-title":"J. Neurobiol."},{"key":"10.1016\/j.neuint.2024.105679_bib67","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00702-010-0376-9","article-title":"Alteration of inhibitory circuits in the somatosensory cortex of Ts65Dn mice, a model for Down's syndrome","volume":"117","author":"P\u00e9rez-Cremades","year":"2010","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.neuint.2024.105679_bib68","doi-asserted-by":"crossref","DOI":"10.1111\/j.1460-9568.2008.06250.x","article-title":"Brain-derived neurotropic factor and neurogenesis in the adult rat dentate gyrus: Interactions with corticosterone","volume":"27","author":"Pinnock","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuint.2024.105679_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroscience.2008.07.025","article-title":"Abnormal expression of synaptic proteins and neurotrophin-3 in the down syndrome mouse model Ts65Dn","volume":"156","author":"Pollonini","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2024.105679_bib70","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejphar.2014.02.046","article-title":"Low-dose combination of Rho kinase and L-type Ca(2+) channel antagonists for selective inhibition of depolarization-induced sustained arterial contraction","volume":"732","author":"Porras-Gonz\u00e1lez","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuint.2024.105679_bib71","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1161\/01.STR.0000181077.84981.11","article-title":"Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection","volume":"36","author":"Rikitake","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.neuint.2024.105679_bib72","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/584071","article-title":"Mouse models of down syndrome as a tool to unravel the causes of mental disabilities","author":"Rueda","year":"2012","journal-title":"Neural Plast."},{"key":"10.1016\/j.neuint.2024.105679_bib73","doi-asserted-by":"crossref","first-page":"10349","DOI":"10.1523\/JNEUROSCI.1409-18.2018","article-title":"Synaptotoxicity in alzheimer's disease involved a dysregulation of actin cytoskeleton dynamics through cofilin 1 phosphorylation","volume":"38","author":"Rush","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2024.105679_bib74","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1083\/jcb.200405002","article-title":"Regulation of SNAREs by tomosyn and ROCK: implication in extension and retraction of neurites","volume":"166","author":"Sakisaka","year":"2004","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.neuint.2024.105679_bib75","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1542\/peds.2009-0745","article-title":"Prevalence of Down syndrome among children and adolescents in 10 regions of the United States","volume":"124","author":"Shin","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.neuint.2024.105679_bib76","first-page":"387","article-title":"Dendritic organization in the neurons of the visual and motor cortices of the cat","volume":"87","author":"Sholl","year":"1953","journal-title":"J. Anat."},{"key":"10.1016\/j.neuint.2024.105679_bib77","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1111\/j.1471-4159.2006.03971.x","article-title":"Altered signaling pathways underlying abnormal hippocampal synaptic plasticity in the Ts65Dn mouse model of Down syndrome","volume":"98","author":"Siarey","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuint.2024.105679_bib78","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/cns.12116","article-title":"Rho kinase inhibitor fasudil protects against \u03b2-amyloid-induced hippocampal neurodegeneration in rats","volume":"19","author":"Song","year":"2013","journal-title":"CNS Neurosci. Ther."},{"issue":"Suppl. l","key":"10.1016\/j.neuint.2024.105679_bib79","first-page":"12","article-title":"Epilepsy in Down syndrome: clinical aspects and possible mechanisms","volume":"98","author":"Stafstrom","year":"1993","journal-title":"Am. J. Ment. Retard."},{"key":"10.1016\/j.neuint.2024.105679_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2014.12.005","article-title":"Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice","volume":"74","author":"Stagni","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2024.105679_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061689","article-title":"Pharmacotherapy with fluoxetine restores functional Connectivity from the dentate gyrus to Field CA3 in the Ts65Dn mouse model of down syndrome","volume":"8","author":"Stagni","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuint.2024.105679_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2017.03.012","article-title":"Long-term effect of neonatal inhibition of APP gamma-secretase on hippocampal development in the Ts65Dn mouse model of Down syndrome","volume":"103","author":"Stagni","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2024.105679_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.05.005","article-title":"Neonatal treatment with cyclosporine A restores neurogenesis and spinogenesis in the Ts65Dn model of Down syndrome","volume":"129","author":"Stagni","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuint.2024.105679_bib84","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00335-011-9321-y","article-title":"Transcript catalogs of human chromosome 21 and orthologous chimpanzee and mouse regions","volume":"22","author":"Sturgeon","year":"2011","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.neuint.2024.105679_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(81)90314-0","article-title":"Abnormal neuronal development in the visual cortex of the human fetus and infant with down's syndrome. A quantitative and qualitative Golgi study","volume":"225","author":"Takashima","year":"1981","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2024.105679_bib86","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0387-7604(89)80082-8","article-title":"Dendrites, dementia and the Down syndrome","volume":"11","author":"Takashima","year":"1989","journal-title":"Brain Dev."},{"key":"10.1016\/j.neuint.2024.105679_bib87","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1093\/brain\/aws254","article-title":"Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's disease","volume":"135","author":"T\u00f6nges","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.neuint.2024.105679_bib88","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1167\/tvst.6.3.22","article-title":"Fasudil, a Clinically used ROCK inhibitor, Stabilizes Rod Photoreceptor synapses after retinal detachment","volume":"6","author":"Townes-Anderson","year":"2017","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.neuint.2024.105679_bib89","doi-asserted-by":"crossref","DOI":"10.1038\/40187","article-title":"Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension","volume":"389","author":"Uehata","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neuint.2024.105679_bib90","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/sj.npp.1301183","article-title":"Chronic fluoxetine treatment increases the expression of PSA-NCAM in the medial prefrontal cortex","volume":"32","author":"Varea","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuint.2024.105679_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2007.08.016","article-title":"Differential evolution of PSA-NCAM expression during aging of the rat telencephalon","volume":"30","author":"Varea","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuint.2024.105679_bib92","first-page":"101","article-title":"Morphological alterations in the hippocampus of the Ts65Dn mouse model for Down syndrome correlate with structural plasticity markers","volume":"33","author":"Villarroya","year":"2018","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.neuint.2024.105679_bib93","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0887-8994(02)00380-6","article-title":"Perinatal growth of prefrontal layer III pyramids in down syndrome","volume":"27","author":"Vuk\u0161i\u0107","year":"2002","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.neuint.2024.105679_bib94","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1083\/jcb.201510107","article-title":"DSCR1 is required for both axonal growth cone extension and steering","volume":"213","author":"Wang","year":"2016","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.neuint.2024.105679_bib95","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1038\/emboj.2012.190","article-title":"DSCR1 interacts with FMRP and is required for spine morphogenesis and local protein synthesis","volume":"31","author":"Wang","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.neuint.2024.105679_bib96","doi-asserted-by":"crossref","first-page":"32","DOI":"10.5114\/fn.2021.105130","article-title":"Fasudil ameliorates cognitive deficits, oxidative stress and neuronal apoptosis via inhibiting ROCK\/MAPK and activating Nrf2 signalling pathways in APP\/PS1 mice","volume":"59","author":"Wei","year":"2021","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.neuint.2024.105679_bib97","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0197-4580(93)90112-O","article-title":"New stereological methods for counting neurons","volume":"14","author":"West","year":"1993","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuint.2024.105679_bib98","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2006-3448","article-title":"Fetal Down syndrome brains exhibit aberrant levels of neurotransmitters critical for normal brain development","volume":"120","author":"Whittle","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.neuint.2024.105679_bib99","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.4103\/1673-5374.303034","article-title":"Environmental enrichment combined with fasudil treatment inhibits neuronal death in the hippocampal CA1 region and ameliorates memory deficits","volume":"16","author":"Xu","year":"2021","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.neuint.2024.105679_bib100","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.brainres.2007.04.013","article-title":"Fasudil, a Rho kinase (ROCK) inhibitor, protects against ischemic neuronal damage in vitro and in vivo by acting directly on neurons","volume":"1154","author":"Yamashita","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.neuint.2024.105679_bib101","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2174\/1871527315666160711104719","article-title":"Multitarget therapeutic effect of fasudil in APP\/PS1transgenic mice","volume":"16","author":"Yu","year":"2017","journal-title":"CNS Neurol. Disord.: Drug Targets"},{"key":"10.1016\/j.neuint.2024.105679_bib102","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2018.00216","article-title":"Fasudil in combination with Bone Marrow Stromal cells (BMSCs) attenuates alzheimer's disease-related changes through the regulation of the Peripheral immune system","volume":"10","author":"Yu","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuint.2024.105679_bib103","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19061821","article-title":"Rho GTPases in intellectual disability: from genetics to therapeutic opportunities","author":"Zamboni","year":"2018","journal-title":"Int. J. Mol. Sci."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018624000068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018624000068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T10:02:54Z","timestamp":1759312974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018624000068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":103,"alternative-id":["S0197018624000068"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2024.105679","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early chronic fasudil treatment rescues hippocampal alterations in the Ts65Dn model for down syndrome","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2024.105679","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"105679"}}